一种解聚金属-Aβ聚集体的硫磺素T类荧光螯合剂

张勇 张哲 董雄伟 尹文星 章丹 刘长林

引用本文: 张勇, 张哲, 董雄伟, 尹文星, 章丹, 刘长林. 一种解聚金属-Aβ聚集体的硫磺素T类荧光螯合剂[J]. 无机化学学报, 2015, 31(8): 1495-1504. doi: 10.11862/CJIC.2015.233 shu
Citation:  ZHANG Yong, ZHANG Zhe, DONG Xiong-Wei, YIN Wen-Xing, ZHANG Dan, LIU Chang-Lin. A Thioflavin T-Based Fluorescent Chelator Disaggregated Metal-Aβ Aggregates[J]. Chinese Journal of Inorganic Chemistry, 2015, 31(8): 1495-1504. doi: 10.11862/CJIC.2015.233 shu

一种解聚金属-Aβ聚集体的硫磺素T类荧光螯合剂

    通讯作者: 刘长林,E-mail:liuchl@mail.ccnu.edu.cn
  • 基金项目:

    国家自然科学基金(No.21302059,21271079,21072074) (No.21302059,21271079,21072074)

    湖北省教育厅青年人才(No.Q20134402)资助项目。 (No.Q20134402)

摘要: 以硫磺素T为母体,合成和表征了一种解聚金属-Aβ聚集体的荧光螯合剂5-氨基-2-(苯并[d]噻唑-2-基)苯酚(FC-9),研究了它与金属-Aβ聚集体的相互作用以及由此导致的Aβ聚集体的构象、形貌和毒性变化。结果表明,FC-9不仅能识别各种Aβ40/Aβ42聚集体,而且还能使金属-Aβ40/42聚集体解聚。FC-9与金属-Aβ聚集体相互作用后,聚集体的形貌由纤维状转化为无定形状,其β-折叠构象也减少了。FC-9还能够跨过细胞膜,符合严格的Lipinski类药标准,在一定程度上可抑制由Cu-Aβ40聚集体产生的毒性,这使得FC-9在螯合治疗老年痴呆症方面可能具有潜在的应用前景。

English

  • 
    1. [1] Adlard P A, Bush A I. J. Alzheimer's Dis., 2006,10:145-163[1] Adlard P A, Bush A I. J. Alzheimer's Dis., 2006,10:145-163

    2. [2] Hardy J A, Higgins G A. Science, 1992,256:184-185[2] Hardy J A, Higgins G A. Science, 1992,256:184-185

    3. [3] Karran E, Mercken M, Strooper B D. Nature, 2011,10:698-712[3] Karran E, Mercken M, Strooper B D. Nature, 2011,10:698-712

    4. [4] Bush A I. Trends Neurosci., 2003,26:207-214[4] Bush A I. Trends Neurosci., 2003,26:207-214

    5. [5] Lovell M A, Robertson J D, Teesdale W J, et al. J. Neurol. Sci., 1998,158:47-52[5] Lovell M A, Robertson J D, Teesdale W J, et al. J. Neurol. Sci., 1998,158:47-52

    6. [6] Bush A I, Tanzi R E. Neurotherapeutics, 2008,5:421-432[6] Bush A I, Tanzi R E. Neurotherapeutics, 2008,5:421-432

    7. [7] Perez L R, Franz K J. Dalton Trans., 2010,39:2177-2187[7] Perez L R, Franz K J. Dalton Trans., 2010,39:2177-2187

    8. [8] Scott L E, Orvig C. Chem. Rev., 2009,109:4885-4910[8] Scott L E, Orvig C. Chem. Rev., 2009,109:4885-4910

    9. [9] Faller P, Hureau C, Penna G L. Acc. Chem. Res., 2014,47:2252-2259[9] Faller P, Hureau C, Penna G L. Acc. Chem. Res., 2014,47:2252-2259

    10. [10] Rodríguez-Rodríguez C, Sánchez de G N, Rimola A, et al. J. Am. Chem. Soc., 2009,131:1436-1451[10] Rodríguez-Rodríguez C, Sánchez de G N, Rimola A, et al. J. Am. Chem. Soc., 2009,131:1436-1451

    11. [11] Chen T, Wang X, He Y, et al. Inorg. Chem., 2009,48:5801-5809[11] Chen T, Wang X, He Y, et al. Inorg. Chem., 2009,48:5801-5809

    12. [12] Zhang Y, Chen L Y, Yin W X, et al. Dalton Trans., 2011, 40:4830-4833[12] Zhang Y, Chen L Y, Yin W X, et al. Dalton Trans., 2011, 40:4830-4833

    13. [13] Sharma A K, Pavlova S T, Kim J, et al. J. Am. Chem. Soc., 2012,134:6625-6636[13] Sharma A K, Pavlova S T, Kim J, et al. J. Am. Chem. Soc., 2012,134:6625-6636

    14. [14] Savelieff M G, Liu Y Z, Senthamarai R R P, et al. Chem. Commun., 2014,50:5301-5303[14] Savelieff M G, Liu Y Z, Senthamarai R R P, et al. Chem. Commun., 2014,50:5301-5303

    15. [15] Kochi A, Eckroat T J, Green K D, et al. Chem. Sci., 2013,4:4137-4145[15] Kochi A, Eckroat T J, Green K D, et al. Chem. Sci., 2013,4:4137-4145

    16. [16] Jones M R, Service E L, Thompson J R, et al. Metallomics, 2012,4:910-920[16] Jones M R, Service E L, Thompson J R, et al. Metallomics, 2012,4:910-920

    17. [17] Lee S, Zheng X, Krishnamoorthy J, et al. J. Am. Chem. Soc., 2014,136:299-310[17] Lee S, Zheng X, Krishnamoorthy J, et al. J. Am. Chem. Soc., 2014,136:299-310

    18. [18] Nol S, Cadet S, Gras E, et al. Chem. Soc. Rev., 2013,42:7747-7762[18] Nol S, Cadet S, Gras E, et al. Chem. Soc. Rev., 2013,42:7747-7762

    19. [19] Savelie M G, DeToma A S, Derrick J S, et al. Acc. Chem. Res., 2014,47:2475-2482[19] Savelie M G, DeToma A S, Derrick J S, et al. Acc. Chem. Res., 2014,47:2475-2482

    20. [20] Adlard P A, Sedjahtera A, Gunawan L, et al. Aging Cell, 2014,13:351-359[20] Adlard P A, Sedjahtera A, Gunawan L, et al. Aging Cell, 2014,13:351-359

    21. [21] Klunk W E, Wang Y, Huang G F, et al. Life Sci., 2001,69:1471-1484[21] Klunk W E, Wang Y, Huang G F, et al. Life Sci., 2001,69:1471-1484

    22. [22] Sheldrick G M. SHELXS-97, A Program for the Solution of Crystal Structures, University of Göttingen, Germany, 1997.[22] Sheldrick G M. SHELXS-97, A Program for the Solution of Crystal Structures, University of Göttingen, Germany, 1997.

    23. [23] Sheldrick G M. SHELXL-97, A Program for the Refinement of Crystal Structures, University of Göttingen, Germany, 1997.[23] Sheldrick G M. SHELXL-97, A Program for the Refinement of Crystal Structures, University of Göttingen, Germany, 1997.

    24. [24] Harry L Ⅲ. Protein Sci., 1993,2:404-410[24] Harry L Ⅲ. Protein Sci., 1993,2:404-410

    25. [25] Hatcher L Q, Hong L, Bush W D, et al. J. Phys. Chem. B, 2008,112:8160-8164[25] Hatcher L Q, Hong L, Bush W D, et al. J. Phys. Chem. B, 2008,112:8160-8164

    26. [26] Tugu V, Karafin A, Palumaa P. J. Neurochem., 2008,104:1249-1259[26] Tugu V, Karafin A, Palumaa P. J. Neurochem., 2008,104:1249-1259

    27. [27] Faller P, Hureau C. Dalton Trans., 2009:1080-1094[27] Faller P, Hureau C. Dalton Trans., 2009:1080-1094

    28. [28] Ha C, Ryu J, Park C B. Biochemistry, 2007,46:6118-6125[28] Ha C, Ryu J, Park C B. Biochemistry, 2007,46:6118-6125

    29. [29] Huang T H, Yang D S, Plaskos N P, et al. J. Mol. Biol., 2000,297:73-87[29] Huang T H, Yang D S, Plaskos N P, et al. J. Mol. Biol., 2000,297:73-87

    30. [30] Lipinski C A, Lombardo F, Dominy B W, et al. Adv. Drug Delivery Rev., 1997,23:3-25[30] Lipinski C A, Lombardo F, Dominy B W, et al. Adv. Drug Delivery Rev., 1997,23:3-25

    31. [31] Clark D E, Pickett S D. Drug Discov. Today, 2000,5:49-58[31] Clark D E, Pickett S D. Drug Discov. Today, 2000,5:49-58

  • 加载中
计量
  • PDF下载量:  0
  • 文章访问数:  919
  • HTML全文浏览量:  144
文章相关
  • 收稿日期:  2014-10-31
  • 网络出版日期:  2015-05-05
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

/

返回文章